FluroTech Announces Filing of Patent Applications With Respect to Its Proprietary Diagnostic Test Method and Pandemic Defense Platform

CALGARY, Alberta, Oct. 22, 2020 (GLOBE NEWSWIRE) — FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that FluroTest LLC (“FluroTest”), a company in which the Company has an equity interest, has filed patent applications with the United States Patent and Trademark Office with respect to certain aspects of its proprietary test method and “Pandemic Defense Platform” (the “Platform”).

FluroTest’s patent pending Platform will be offered both on a turn-key basis to third parties seeking to operate their own testing solution as well as on a “testing as a service” offering to be operated by FluroTest, serving communities seeking a total solution for surge-scale, high-volume testing services necessary to safely open their environments at scale. The Platform will be available for deployment in Latin America immediately, and will be available for deployment in the United States, Canada and Europe, pending regulatory approval.